Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

" Digitalization of Neurofunctional Tests Via a Mobile Application, Digital Assessment Multiple Sclerosis (DAMS), for Multiple Sclerosis Patients"

NCT03148938 is registered in ClinicalTrials.gov with Ad scientiam as lead sponsor.

NCT NCT03148938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03148938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
" Digitalization of Neurofunctional Tests Via a Mobile Application, Digital Assessment Multiple Sclerosis (DAMS), for Multiple Sclerosis Patients"
Lead sponsor
Ad scientiam
Phase
Not applicable
Overall status
Completed
Start date
October 2, 2017
Completion date
August 29, 2018
Enrollment
222 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis